Angevin

adj.

安茹省的，金雀花王朝的，安茹王朝的；

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or ...
Borg, C. et al. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J. Clin. In...
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expres...
Tumor-derived exosomes: a new source of tumor rejection antigens
Exosome-based immunotherapy
Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy
Ex ante assessment of the sustainability of alternative cropping systems: implications for using multi-criteria decision-aid methods...
Phase II trial of thalidomide in renal-cell carcinoma